Paper17539055
Therapies for Alzheimer's disease.
Melnikova I. Nat Rev Drug Discov, 2007. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. Therapies for Alzheimer's disease. Papers, record 17539055. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17539055
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Alzheimer Vaccines | |
| Amyloid Precursor Protein Secretases | |
| Amyloid beta-Peptides | |
| Cholinesterase Inhibitors | |
| Clinical Trials as Topic | |
| Excitatory Amino Acid Antagonists | |
| GABA Agonists | |
| Humans | |
| Immunization | |
| Memantine | |
| Receptors, N-Methyl-D-Aspartate | |
| Taurine |
Source PubMed
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42389265 | Advances in the treatment of Alzheimer's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42389265 | PubMed |
| 42166149 | Cell type transcriptomic modules reveal shared molecular mechanisms in Alzheimer's and Parkinson's disease. | Gigascience | 2026 | https://conductscience.org/library/papers/42166149 | PubMed |
| 39814937 | DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer's disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/39814937 | PubMed |
| 39456229 | Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456229 | PubMed |
| 38027768 | Network pharmacology and in vivo studies reveal the neuroprotective effects of paeoniflorin on Alzheimer's disease. | Heliyon | 2023 | https://conductscience.org/library/papers/38027768 | PubMed |
| 36984830 | Natural Corynanthe-Type Cholinesterase Inhibitors from Malaysian Uncaria attenuata Korth.: Isolation, Characterization, In Vitro and In Silico Studies. | Metabolites | 2023 | https://conductscience.org/library/papers/36984830 | PubMed |
| 36903581 | Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease. | Molecules | 2023 | https://conductscience.org/library/papers/36903581 | PubMed |
| 35701806 | Mechanistic insight of the potential of geraniol against Alzheimer's disease. | Eur J Med Res | 2022 | https://conductscience.org/library/papers/35701806 | PubMed |
| 35630613 | Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors. | Molecules | 2022 | https://conductscience.org/library/papers/35630613 | PubMed |
| 34975502 | Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer's Disease From the Perspective of Pathophysiological Processes. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34975502 | PubMed |
| 34904048 | Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease. | World J Biol Chem | 2021 | https://conductscience.org/library/papers/34904048 | PubMed |
| 34220245 | Cholinesterase inhibitory activity of tinosporide and 8-hydroxytinosporide isolated from Tinospora cordifolia: In vitro and in silico studies targeting management of Alzheimer's disease. | Saudi J Biol Sci | 2021 | https://conductscience.org/library/papers/34220245 | PubMed |
| 34203850 | Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34203850 | PubMed |
| 33934227 | Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/33934227 | PubMed |
| 33807157 | The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer's Disease Mechanism Determined by a Network Pharmacology Approach. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33807157 | PubMed |
| 33509748 | [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease]. | Nan Fang Yi Ke Da Xue Xue Bao | 2021 | https://conductscience.org/library/papers/33509748 | PubMed |
| 33504788 | Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs. | Nat Commun | 2021 | https://conductscience.org/library/papers/33504788 | PubMed |
| 32952669 | Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. | Asian J Pharm Sci | 2020 | https://conductscience.org/library/papers/32952669 | PubMed |
| 32948022 | Drugs Modulating CD4+ T Cells Blood-Brain Barrier Interaction in Alzheimer's Disease. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32948022 | PubMed |
| 32244635 | Ajmalicine and Reserpine: Indole Alkaloids as Multi-Target Directed Ligands Towards Factors Implicated in Alzheimer's Disease. | Molecules | 2020 | https://conductscience.org/library/papers/32244635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17539055
GET https://conductscience.org/api/papers/v1/17539055/cited_by?page=2